Zomedica Pharmaceuticals Corp. Contracts & Agreements

Lease Agreement entered into as of November 15, 2024 by and between 1101 Technology Drive, L.L.C. and Zomedica Inc (Filed With SEC on November 19, 2024)

Stock Appreciation Rights Agreement (Employees) (Filed With SEC on November 7, 2024)

Stock Appreciation Rights Agreement (Directors) (Filed With SEC on November 7, 2024)

Stock Appreciation Rights Plan (Filed With SEC on November 7, 2024)

Stock Appreciation Rights Agreement (Employees) (Filed With SEC on August 14, 2024)

Stock Appreciation Rights Agreement (Directors) (Filed With SEC on August 14, 2024)

Consulting Agreement, dated August 14, 2024, between Zomedica Inc. and Peter Donato (Filed With SEC on August 14, 2024)

Separation Agreement, dated August 14, 2024, between Zomedica Inc. and Peter Donato (Filed With SEC on August 14, 2024)

Offer letter, dated November 6, 2023, among Zomedica Inc., Zomedica Corp., and Russell Kevin Klass (Filed With SEC on May 9, 2024)

License Agreement, effective November 1, 2021, by and between The Wheelership LLC and Assisi Animal Health, as assumed by Zomedica Inc. effective July 15, 2022 (Filed With SEC on April 1, 2024)

Form of Indemnity (Filed With SEC on April 1, 2024)

Amendment to Executive Employment Agreement of Larry C. Heaton dated April 1, 2024 (Filed With SEC on April 1, 2024)

Amendment to Offer letter of Peter Donato dated April 1, 2024 (Filed With SEC on April 1, 2024)

LLC Membership Interest Purchase Agreement dated October 4, 2023 by and between Zomedica Inc. and Qorvo US, Inc (Filed With SEC on October 10, 2023)

First Amendment to BAW Sensor Supply Agreement (Filed With SEC on October 10, 2023)

Stock Purchase Agreement dated September 4, 2023 by and between Zomedica Inc., Sellers and SMP VG Holdco Inc (Filed With SEC on September 6, 2023)

First Amendment to Multi-Tenant Industrial Triple Net Lease entered into as of May 10, 2023 by and between ULF Northfield Business Center LL and Zomedica Inc (Filed With SEC on May 11, 2023)

Separation Agreement, dated March 16, 2023, between Zomedica Inc. and Ann Marie Cotter (Filed With SEC on March 17, 2023)

Offer Letter, dated March 15, 2023, between Zomedica Inc. and Peter Donato (Filed With SEC on March 17, 2023)

License Agreement, effective November 1, 2021, by and between The Wheelership LLC and Assisi Animal Health, as assumed by Zomedica Inc. effective July 15, 2022 (Filed With SEC on March 15, 2023)

Form of Indemnity (Filed With SEC on March 15, 2023)

Transition and Support Agreement by and among Qorvo Biotechnologies, LLC, Zomedica Inc. and Zomedica Corp (Filed With SEC on January 24, 2023)

BAW Sensor Supply Agreement by and among Qorvo Biotechnologies, LLC, Zomedica Inc. and Zomedica Corp (Filed With SEC on January 24, 2023)

Development and Manufacturing License Agreement by and among Qorvo Biotechnologies, LLC, Zomedica Inc. and Zomedica Corp (Filed With SEC on January 24, 2023)

Structured Monitoring Products, Inc. Distribution Agreement dated January 13, 2023 by and between Zomedica Inc. and Structured Monitoring Products, Inc (Filed With SEC on January 20, 2023)

Lease Agreement, effective July 1, 2022 by and between Zomedica Inc. and Lebow 1031 Legacy, LLC (Filed With SEC on November 14, 2022)

Consulting Agreement, effective June 17, 2022, by and between Zomedica Corp. and Dr. Stephanie Morley (Filed With SEC on August 15, 2022)

Lease Agreement, effective April 1, 2022, by and between Zomedica Inc. and ULF Northfield Business Center (Filed With SEC on August 15, 2022)

Note receivable agreement, effective May 16, 2022, by and between Zomedica, Inc. and Structured Monitoring Products, Inc (Filed With SEC on August 15, 2022)

Asset Purchase Agreement dated July 15, 2022 by and among Assisi Animal Health LLC, AAH Holdings LLC, the Principal Members (as defined therein), Zomedica Inc. and Zomedica Corp (Filed With SEC on July 20, 2022)

Warrant to Purchase Common Shares dated July 15, 2022 issued to Assisi Animal Health LLC (Filed With SEC on July 20, 2022)

Warrant to Purchase Common Shares dated July 1, 2022 issued to Revo Squared LLC (Filed With SEC on July 11, 2022)

Asset Purchase Agreement dated June 14, 2022 by and among Revo Squared LLC, the Principal Member (as defined therein), Zomedica Inc. and Zomedica Corp (Filed With SEC on June 21, 2022)

Consulting Agreement, effective March 1, 2022, by and between Zomedica Inc. and Johnny D. Powers (Filed With SEC on May 10, 2022)

Summary of Compensation Arrangements with Ann Marie Cotter (Filed With SEC on March 1, 2022)

Confidential Separation Agreement and Release Agreement, dated November 19, 2021, between Zomedica Inc. and Bruk Herbst (Filed With SEC on November 26, 2021)

Second Lease Agreement, effective September 15, 2021, by and between Zomedica Inc. and Wickfield Phoenix LLC (Filed With SEC on November 12, 2021)

Executive Employment Agreement, dated September 6, 2019, by and between Pulse Veterinary Technologies, LLC and Adrian Lock (Filed With SEC on November 12, 2021)

Executive Employment Agreement, dated October 1, 2021, among Zomedica Inc., Zomedica Corp. and Larry Heaton (Filed With SEC on October 4, 2021)

Stock Purchase Agreement dated October 1, 2021 by and between Zomedica Inc. and Branford PVT Mid-Hold, LLC (Filed With SEC on October 1, 2021)

Separation Agreement between the Company and Stephanie Morley, dated May 14, 2021 (Filed With SEC on May 17, 2021)

Consulting Agreement between the Company and Stephanie Morley, dated May 14, 2021 (Filed With SEC on May 17, 2021)

Form of Indemnity (Filed With SEC on February 26, 2021)

Amended and Restated Underwriting Agreement, dated February 8, 2021, between Zomedica Corp. and H.C. Wainwright & Co., LLC (Filed With SEC on February 9, 2021)

Executive Employment Agreement, dated January 1, 2021 among Zomedica Pharmaceuticals, Inc., Zomedica Corp. and Robert Cohen (Filed With SEC on January 5, 2021)

Executive Employment Agreement, dated September 19, 2019, by and between Zomedica Pharmaceuticals Inc. and Stephanie Morley, and the amendment thereto dated December 23, 2020 (Filed With SEC on December 23, 2020)

Executive Employment Agreement, dated July 1, 2017, by and between Zomedica Pharmaceuticals Inc. and Bruk Herbst, and the amendments thereto dated November 19, 2020 and December... (Filed With SEC on December 23, 2020)

Amendment, dated August 14, 2020, to Development and Supply Agreement with Qorvo Biotechnologies, LLC (Filed With SEC on October 9, 2020)

Letter Agreement, dated September 3, 2020, with Qorvo Biotechnologies, LLC (Filed With SEC on October 9, 2020)

Form of Series D Warrant (Filed With SEC on July 6, 2020)

Form of Pre-Funded Warrant (Filed With SEC on July 6, 2020)

Placement Agency Agreement, dated July 1, 2020, by and between the Company and H.C. Wainwright & Co., LLC (Filed With SEC on July 6, 2020)

Form of Securities Purchase Agreement, dated July 1, 2020, by and among the Company and the purchasers party thereto (Filed With SEC on July 6, 2020)

Amended and Restated Executive Employment Agreement, dated June 16, 2020, among Zomedica Pharmaceuticals, Inc., Zomedica Pharmaceuticals Corp. and Robert Cohen (Filed With SEC on July 1, 2020)

Executive Employment Agreement, dated June 16, 2020, among Zomedica Pharmaceuticals, Inc., Zomedica Pharmaceuticals Corp. and Robert Cohen (Filed With SEC on June 17, 2020)

Form of Placement Agency Agreement to be entered into by and between the Company and H.C. Wainwright & Co., LLC (Filed With SEC on May 22, 2020)

Form of Placement Agency Agreement to be entered into by and between the Company and H.C. Wainwright & Co., LLC (Filed With SEC on May 15, 2020)

Form of Series C Warrant (Filed With SEC on May 15, 2020)

Form of Pre-Funded Warrant (Filed With SEC on May 15, 2020)

Form of Placement Agent Warrant (Filed With SEC on May 15, 2020)

Form of Securities Purchase Agreement to be entered into among the Company and certain investors (Filed With SEC on May 15, 2020)

Promissory Note, between Bank of America, NA and Zomedica Pharmaceuticals Corp., dated April 15, 2020 (Filed With SEC on April 24, 2020)

Form of Warrant (Filed With SEC on April 8, 2020)

Form of Placement Agent Warrant (Filed With SEC on April 8, 2020)

Placement Agency Agreement, dated April 7, 2020, by and between the Company and H.C. Wainwright & Co., LLC (Filed With SEC on April 8, 2020)

Form of Securities Purchase Agreement, dated April 7, 2020, by and between the Company and the purchasers party thereto (Filed With SEC on April 8, 2020)

Description of Securities (Filed With SEC on February 26, 2020)

Amended and Restated Exclusive License and Supply Agreement, dated January 17, 2020, by and between Celsee, Inc. and Zomedica Pharmaceuticals Corp (Filed With SEC on February 26, 2020)

Lease Agreement for 100 Phoenix Drive, Ann Arbor, 48108 (Filed With SEC on February 26, 2020)

Consulting Agreement between Zomedica Pharmaceuticals Corp. and Johnny D. Powers (Filed With SEC on February 26, 2020)

Form of Warrant (Filed With SEC on February 13, 2020)

Form of Placement Agent Warrant (Filed With SEC on February 13, 2020)

Form of Securities Purchase Agreement, dated February 12, 2020, by and between the Company and the Purchasers (Filed With SEC on February 13, 2020)

Separation Agreement between the Company and Gerald Solensky, Jr. dated December 2, 2019 (Filed With SEC on December 3, 2019)

Cooperation Agreement between the Company and Gerald Solensky, Jr. dated December 2, 2019 (Filed With SEC on December 3, 2019)

Consulting Agreement among the Company, Zomedica Pharmaceuticals, Inc. and Gerald Solensky, Jr. dated December 2, 2019 (Filed With SEC on December 3, 2019)

Executive Employment Agreement, dated September 16, 2019, by and between Zomedica Pharmaceuticals Inc. and Stephanie Morley (Filed With SEC on September 17, 2019)

Form of Preferred Share Subscription Agreement for May 2019 Offering (Filed With SEC on May 10, 2019)

Underwriting Agreement, dated March 26, 2019, by an among the Company and the Representative on behalf of the several Underwriters (Filed With SEC on March 27, 2019)

Development and supply agreement with Qorvo Biotechnologies, LLC (Filed With SEC on February 26, 2019)

Amendment No. 2 to Executive Employment Agreement between Zomedica Pharmaceuticals Corp. and Gerald Solensky, Jr (Filed With SEC on February 26, 2019)

First Amendment to Lease Agreement for 100 Phoenix Drive, Ann Arbor MI 48108 (Filed With SEC on November 13, 2018)

Addendum to First Amendment to Lease Agreement 100 Phoenix Drive, Ann Arbor MI 48108 (Filed With SEC on November 13, 2018)

Development, Commercialization and Exclusive Distribution Agreement, dated May 10, 2018, by and between Seraph Biosciences, Inc. and Zomedica Pharmaceuticals Corp (Filed With SEC on August 9, 2018)

License and Supply Agreement, dated December 20, 2017, by and between Celsee, Inc. and Zomedica Pharmaceuticals Corp (Filed With SEC on February 28, 2018)

Loan Agreement, dated October 17, 2017, by and between Zomedica Pharmaceuticals Corp. and Equidebt LLC (Filed With SEC on November 9, 2017)

Line of Credit Promissory Note, dated October 17, 2017, from Zomedica Pharmaceuticals Corp. in favor of Equidebt LLC (Filed With SEC on November 9, 2017)

Guaranty Agreement, dated October 17, 2017 made by Gerald A. Solensky in favor of Equidebt LLC (Filed With SEC on November 9, 2017)

Employment Agreement between ZoMedica Pharmaceuticals Inc. and Stephanie Morley (Filed With SEC on September 1, 2017)

Consulting AgreementAgreement between ZoMedica Pharmaceuticals Inc. and William MacArthur (Filed With SEC on September 1, 2017)

Executive Employment Agreement between ZoMedica Pharmaceuticals Inc. and Bruk Herbst (Filed With SEC on September 1, 2017)

Amendment No. 1 to Executive Employment Agreement between Zomedica Pharmaceuticals Corp. and Gerald Solensky Jr (Filed With SEC on September 1, 2017)

Loan Agreement, dated September 1, 2017, by and between Gerald A. Solensky and Equidebt LLC (Filed With SEC on September 1, 2017)

Line of Credit Promissory Note, dated September 1, 2017, from Gerald A. Solensky in favor of Equidebt LLC (Filed With SEC on September 1, 2017)

AMALGAMATION AGREEMENT THIS AMALGAMATION AGREEMENT made as of the 30thday of March, 2016. (Filed With SEC on April 21, 2017)

CONFIDENTIAL (Filed With SEC on April 21, 2017)

EXECUTIVE EMPLOYMENT AGREEMENT (Filed With SEC on April 21, 2017)

AMENDMENT NO.1 TO EXECUTIVE EMPLOYMENT AGREEMENT (Filed With SEC on April 21, 2017)

EMPLOYMENT AGREEMENT (Filed With SEC on April 21, 2017)

EXECUTIVE EMPLOYMENT AGREEMENT (Filed With SEC on April 21, 2017)

COMMERCIAL LEASE AGREEMENT (Filed With SEC on April 21, 2017)

LEASE SUMMARY (Filed With SEC on April 21, 2017)

ZOMEDICA PHARMACEUTICALS CORP. STOCK OPTION PLAN (Filed With SEC on April 21, 2017)

SUBSCRIPTION FOR COMMON SHARES (Filed With SEC on April 21, 2017)

FORM 2F CPC ESCROW AGREEMENT (Filed With SEC on April 21, 2017)

FORM 5D ESCROW AGREEMENT (VALUE SECURITY) (Filed With SEC on April 21, 2017)

COLLABORATIVE RESEARCH AGREEMENT (Filed With SEC on April 21, 2017)

Category

Industry

Companies

Contracts

Zomedica Pharmaceuticals Corp. Contracts & Agreements